Clinical Trials
Clinical trials are essential to advancing medical knowledge and improving patient care. At United Health Services Hospitals (UHSH), we conduct clinical trials to evaluate new treatments, technologies, and approaches to care — all while upholding the highest standards of safety, ethics, and patient-centeredness.
Participating in a clinical trial at UHSH gives patients access to promising new therapies and contributes to innovations that benefit our community and beyond.
Why Participate in a Clinical Trial?
- Access to new treatments before they become widely available
- Close monitoring by experienced clinical staff
- Opportunity to contribute to medical progress and help future patients
- Voluntary participation — patients may leave a study at any time
- Ethical oversight — all studies are reviewed by the UHSH Institutional Review Board (IRB)
Currently Enrolling Studies
We are currently enrolling in a select number of high-impact clinical studies.
dalGenE 2 (DAL302):
- Brief Description: A phase III, double-blind, randomized placebo-controlled study to evaluate the effects of dalcetrapib on cardiovascular (CV) risk in a genetically defined population with a recent Acute Coronary Syndrome (ACS): The DAL-302 (dal-GenE-2) trial. In previous studies, it was found that participants that had a particular gene improved when on the study drug. In this study, we are enrolling only subjects with that genotype
- Principal Investigator (PI): Hisham Kashou, MD
- Location(s): UHS Wilson Medical Center
- Eligibility Criteria: multiple, but must have the AA genotype to participate
- Enrollment Status: actively screening and enrolling
- Contact Information: research@nyuhs.org
- ClinicalTrials.gov Identifier: NCT02525939
Triamcinolone Ketorolac Knee Trial (TriKe):
- Brief Description: A randomized controlled trial comparing three types of knee injections and collecting patient self-reported symptoms to assess effects for treatment of knee osteoarthritis.
- Principal Investigator (PI): Stanley Hunter, MD
- Location(s): UHS Orthopedic Center
- Eligibility Criteria: multiple, but must have diagnosis of knee osteoarthritis
- Enrollment Status: actively screening and enrolling
- Contact Information: research@nyuhs.org
- ClinicalTrials.gov Identifier: 14028/14762
Contact for Clinical Trial Information:
Have questions about clinical trials at UHS or want to learn more about enrolling in a study?
Email: research@nyuhs.org